Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
Evaluation of Safety, Efficacy, and Immunogenicity of ADVATE in Hemophilia A- An ADVATE Post-authorization Safety Surveillance (PASS) Study
The primary objective of this post-authorization safety surveillance is to measure the incidence of adverse events that are at least possibly related to ADVATE use, in subjects receiving ADVATE in routine clinical practice.
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90027, United States
Iowa City, Iowa 52242, United States
Winston-Salem, North Carolina 27157, United States
Cincinnati, Ohio 45229, United States
Philadelphia, Pennsylvania 19134-1095, United States